- Filed
- Mar 18, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 11, 2025 | 86.5M sh |
| Long Term Debt | FY 2025 · Jan 31, 2024 | $874.97M |
| Short Term Debt | FY 2025 · Jan 31, 2024 | $0 |
| Cash And Equivalents | FY 2025 · Jan 31, 2024 | $403.98M |
| Current Liabilities | FY 2025 · Jan 31, 2024 | $117.09M |
| Total Liabilities | FY 2025 · Jan 31, 2024 | $1.13B |
| Current Assets | FY 2025 · Jan 31, 2024 | $557.44M |
| Total Assets | FY 2025 · Jan 31, 2024 | $3.16B |
| Shares Diluted | FY 2025 · Jan 31, 2023 | 84.44M sh |
| Stock Repurchased | FY 2025 · Jan 31, 2023 | $0 |
| Capex | FY 2025 · Jan 31, 2023 | $3.37M |
| Operating Cash Flow | FY 2025 · Jan 31, 2023 | $150.65M |
| Eps Diluted | FY 2025 · Jan 31, 2023 | −$0.31 |
| Eps Basic | FY 2025 · Jan 31, 2023 | −$0.31 |
| Sga Expense restated | FY 2025 · Jan 31, 2023 | $97.47M |
| Rd Expense | FY 2025 · Jan 31, 2023 | $193.38M |
| Net Income | FY 2025 · Jan 31, 2023 | −$26.14M |
| Operating Income | FY 2025 · Jan 31, 2023 | $9.06M |
| Gross Profit restated | FY 2025 · Jan 31, 2023 | $491.94M |
| Cost Of Revenue restated | FY 2025 · Jan 31, 2023 | $369.81M |
| Revenue | FY 2025 · Jan 31, 2023 | $861.75M |
| Stockholders Equity | FY 2025 · Jan 31, 2022 | $1.85B |